This technology from scientists at Los Alamos National Laboratory represents a novel platform for improving the safety and effectiveness of therapeutic gas-based treatments by enabling controlled, localized delivery at the site of disease. By addressing longstanding challenges associated with systemic exposure and dosing precision, the platform enhances the clinical viability of gas therapies across high-value markets such as oncology, cardiovascular care, and regenerative medicine. In addition, the inclusion of a complementary predictive modeling capability supports treatment optimization and development efficiency, reducing technical risk and accelerating translation. Together, these capabilities position the technology as a differentiated and scalable solution that can unlock new commercial opportunities in areas where gas-based therapeutics have shown promise but faced delivery limitations. The Opportunity: Therapeutic gases have demonstrated meaningful biological effects across oncology, cardiovascular disease, neuroprotection and regenerative medicine, yet their clinical adoption has been limited by a fundamental challenge: safe, controlled and localized delivery. Existing approaches often result in rapid release, systemic exposure or narrow therapeutic windows, creating safety, regulatory and development barriers. The Clathrate Therapeutics Platform addresses this unmet need by positioning gas-based therapies as programmable, targetable and commercially viable treatment modalities. By enabling more precise control over where and how therapeutic gases are delivered, the platform has the potential to unlock new product categories, enhance combination treatment strategies and accelerate translation of gas-based therapeutics into high-value clinical markets. How it Works: The Clathrate Therapeutics Platform uses a proprietary, controlled-release system designed to localize therapeutic gases at the intended treatment site rather than allowing them to disperse...
How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start a free GlobalGov account| Issuing agency | Triad - DoE Contractor |
|---|
| Country | United States |
|---|
| Category | Government Procurement |
|---|
| NAICS | 325412 |
|---|
| PSC | 6505 |
|---|
| Published | June 04, 2026 |
|---|
| Procurement stage | Request for Proposal (RFP) |
|---|
| Response due | December 03, 2026 |
|---|
| Status | Open — accepting responses |
|---|
| Official source | View original notice |
|---|
| Last verified | October 11, 2026 |
|---|
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
See every United States Government Procurement opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free United States Government Procurement intelligence report in your inbox
A personalized report on United States Government Procurement opportunities, emailed in 5-10 minutes. One per month, no account needed.